MedTrace Logo

Efficacy and Safety of Azithromycin and Artesunate in Pregnant Women

NCT00287300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2006-02-06

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of three treatment regimens for the prevention of malaria during pregnancy.

Conditions

Interventions

DRUG

Sulfadoxine-Pyrimethamine

DRUG

Azithromycin

DRUG

Artesunate

Sponsors & Collaborators

Principal Investigators

  • Steve R Meshnick, M.D., Ph.D. · 2. Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill NC USA

  • Stephen J Rogerson, MB BS, Ph.D. · 3. Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Parkville Victoria Australia

  • Marjorie Chaponda, MB BS, MPH · 1. UNC Malaria Project, Department of Community Health, College of Medicine, University of Malawi

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Completion
2005-08-31

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287300 on ClinicalTrials.gov